The use of Artificial Intelligence Algorithms in drug development and clinical trials: A scoping review.

Journal: International journal of medical informatics
PMID: 39827570

Abstract

BACKGROUND: Artificial Intelligence (AI) is transforming drug development and clinical trials, helping researchers find new treatments faster and personalize care for patients. By automating tasks like molecule screening and predicting treatment outcomes, AI addresses critical challenges in modern medicine.

Authors

  • Camila de Brito Pontes
    Universidade Federal de São Paulo (UNIFESP), Brazil. Electronic address: camilapontes085@gmail.com.
  • Antonio Valerio Netto
    Universidade Federal de São Paulo (UNIFESP), professor afiliado do Departamento de Informática em Saúde da Escola Paulista de Medicina (EPM/UNIFESP), Brazil. Electronic address: avnetto@unifesp.br.

Keywords

External Resources

Popular Topics
Recent Journals